Skip to content
Dose Brief
Menu
No. 319 here · Grade C

SkinnyRx review

A desk that puts every term and every rate on the page before a single medical question — and then advertises itself with the twelve-month rung of each one, on a microdose line that costs the same as the full dose.

Visit SkinnyRx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.

On the record

The FDA issued a warning letter to Lean Rx, Inc. dba SkinnyRx in February 2026. SkinnyRx keeps its place here and its link is unchanged — but you should know the letter exists before you start care. Read it in the FDA's warning letter database.

Semaglutide
$349/mo month-to-month, compounded — the advertised $199 is the 12-month rung, billed as $2,388 in one payment
Tirzepatide
$399/mo month-to-month, compounded, injection or tablet at the same price — the advertised $299 is the 12-month rung, billed as $3,588 in one payment
Coverage
47 states + Washington DC — not Alabama, Louisiana or Mississippi
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior reading— First reading, 8 August 2026. Month-to-month is $349 semaglutide and $399 tirzepatide, and the tirzepatide tablet costs exactly what the tirzepatide injection costs at all four terms. The "as low as $199 / $299" the site advertises are the twelve-month rungs, charged as $2,388 and $3,588 up front and auto-renewing annually. The separate microdose line costs the same as full dose at every shared term and floors higher, at $229 and $319, because it stops at eight months.

The scorecard

SkinnyRx scored on our six Brief Score factors. See the methodology.

Price Stability54/100
Supply Reliability58/100
Transparency62/100
Access Breadth74/100
Clinical Oversight55/100
Track Record42/100

What we like

  • Every term and every rate is on the product page before any medical intake — four rungs per SKU, both molecules, both routes — which is more than most of this ranking publishes anywhere
  • The tirzepatide tablet is priced identically to the tirzepatide injection at all four terms, so choosing the needle-free route costs nothing extra here
  • Names the three states it does NOT serve — Alabama, Louisiana and Mississippi — instead of the "select states" most desks say, so a reader can check coverage in one glance
  • A separate low-dose line with its own page and its own intake, for readers who titrate badly at therapeutic doses
  • Concrete terms rather than vague ones: free shipping, unlimited provider messaging, a 90-day money-back guarantee, and no charge at all if a clinician finds you ineligible
  • Both molecules by both routes on one account, so switching route does not mean switching desks

The caveats

  • Every "as low as" figure on the site is a twelve-month rate: $199 semaglutide bills $2,388 in one payment and $299 tirzepatide bills $3,588, each auto-renewing annually. Month-to-month you pay $349 and $399, and the financing option only appears once the term is longer than a month
  • The microdose line costs the SAME as full dose at every term it shares — $349 and $399 month-to-month, $299 and $349 at four months — and its floor is HIGHER, $229 against $199 and $319 against $299, because it stops at eight months instead of twelve. More money for less drug
  • One published price cannot be trusted: the "Compounded Sublingual Semaglutide" tile displays $199 while its checkout price maps to the tirzepatide ladder, so we publish no sublingual semaglutide figure at all rather than guess which one it charges
  • No brand-name route is actually purchasable. Ozempic, Wegovy, Wegovy Pill, Foundayo Pill, Mounjaro and Zepbound all carry no price at checkout and both pills read as out of stock; the only priced brand path is a $49/mo membership "+ Medication Cost", and that medication cost is published nowhere
  • The dispensing pharmacies are never named — only "503A pharmacies" — and no medical director or prescriber is identified anywhere on the consumer pages
  • Compounded semaglutide and tirzepatide are not FDA-approved products, and this desk sells nothing that is
  • FDA issued a warning letter in February 2026 to the company behind this desk; it is disclosed on every surface that ranks it and has not been closed out

The brief

Best for: Readers who will not inject and want a tablet at no premium over the injection, and who will check which term a "$199" is attached to before treating it as a monthly bill. A desk that puts every term and every rate on the page before a single medical question — and then advertises itself with the twelve-month rung of each one, on a microdose line that costs the same as the full dose.

Ranked #319 of 509 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Visit SkinnyRx

Closest here

The desks scoring nearest SkinnyRx — the realistic shortlist if you're weighing it.

Weighing SkinnyRx against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs SkinnyRx, and every desk that outranks it is listed on the SkinnyRx alternatives ranking.

More desks we track (24)

478 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect SkinnyRx's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on SkinnyRx's site. Not medical advice; see our disclosure.

← Back to all rankings